Anti-ANKRD11 monoclonal antibody

Pre-made anti-ANKRD11 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to ANKRD11/ANKRD11 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2343-Ab-1/ GM-Tg-hg-IP2343-Ab-2Anti-Human ANKRD11 monoclonal antibodyHuman
GM-Tg-rg-IP2343-Ab-1/ GM-Tg-rg-IP2343-Ab-2Anti-Rat ANKRD11 monoclonal antibodyRat
GM-Tg-mg-IP2343-Ab-1/ GM-Tg-mg-IP2343-Ab-2Anti-Mouse ANKRD11 monoclonal antibodyMouse
GM-Tg-cynog-IP2343-Ab-1/ GM-Tg-cynog-IP2343-Ab-2Anti-Cynomolgus/ Rhesus macaque ANKRD11 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2343-Ab-1/ GM-Tg-felg-IP2343-Ab-2Anti-Feline ANKRD11 monoclonal antibodyFeline
GM-Tg-cang-IP2343-Ab-1/ GM-Tg-cang-IP2343-Ab-2Anti-Canine ANKRD11 monoclonal antibodyCanine
GM-Tg-bovg-IP2343-Ab-1/ GM-Tg-bovg-IP2343-Ab-2Anti-Bovine ANKRD11 monoclonal antibodyBovine
GM-Tg-equg-IP2343-Ab-1/ GM-Tg-equg-IP2343-Ab-2Anti-Equine ANKRD11 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2343-Ab-1/ GM-Tg-hg-IP2343-Ab-2; GM-Tg-rg-IP2343-Ab-1/ GM-Tg-rg-IP2343-Ab-2;
GM-Tg-mg-IP2343-Ab-1/ GM-Tg-mg-IP2343-Ab-2; GM-Tg-cynog-IP2343-Ab-1/ GM-Tg-cynog-IP2343-Ab-2;
GM-Tg-felg-IP2343-Ab-1/ GM-Tg-felg-IP2343-Ab-2; GM-Tg-cang-IP2343-Ab-1/ GM-Tg-cang-IP2343-Ab-2;
GM-Tg-bovg-IP2343-Ab-1/ GM-Tg-bovg-IP2343-Ab-2; GM-Tg-equg-IP2343-Ab-1/ GM-Tg-equg-IP2343-Ab-2
Products NameAnti-ANKRD11 monoclonal antibody
Formatmab
Target NameANKRD11
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-ANKRD11 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2343-Ag-1Recombinant multi-species ANR11/ ANKRD11/ ANCO-1 protein


    Target information

    Target IDGM-IP2343
    Target NameANKRD11
    Gene ID29123,77087,365023,698722,489658,101100431,532856,100050107
    Gene Symbol and Synonyms2410104C19Rik,3010027A04Rik,6330578C09Rik,9530048I21Rik,ANCO-1,ANCO1,ANKRD11,Gm176,LZ16,T13,Yod
    Uniprot AccessionQ6UB99
    Uniprot Entry NameANR11_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000167522
    Target ClassificationN/A

    The target: ANKRD11, gene name: ANKRD11, also named as ANCO-1, ANCO1, LZ16, T13. This locus encodes an ankryin repeat domain-containing protein. The encoded protein inhibits ligand-dependent activation of transcription. Mutations in this gene have been associated with KBG syndrome, which is characterized by macrodontia, distinctive craniofacial features, short stature, skeletal anomalies, global developmental delay, seizures and intellectual disability. Alternatively spliced transcript variants have been described. Related pseudogenes exist on chromosomes 2 and X. [provided by RefSeq, Jan 2012].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.